Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guideline
SourceCritical Reviews in Oncology Hematology, 84, 2, (2012), pp. 252-260
Article / Letter to editor
Display more detailsDisplay less details
Laboratory of Genetic, Endocrine and Metabolic Diseases
Critical Reviews in Oncology Hematology
SubjectIGMD 6: Hormonal regulation ONCOL 5: Aetiology, screening and detection; ONCOL 3: Translational research; ONCOL 4: Quality of Care
Breast cancer is the most common malignancy amongst women in the developed world. For patients with hormone-sensitive breast cancer eligible for adjuvant hormonal therapy, it is important to know if the ovaries are (still) functional or not. Indeed, the choice for a specific adjuvant hormonal treatment depends on the menopausal status of an individual woman. The currently available measures to determine the menopausal status are conflicting. Until better measures become available, we propose a practical guideline enabling an optimal choice of adjuvant hormonal therapy for women with a hormone receptor positive breast cancer taking into account uncertainties about their menopausal status.
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.